TIS tissue therapies limited

Ann: Regulatory Update , page-8

  1. 2,738 Posts.
    lightbulb Created with Sketch. 6
    I was howled down when I suggested months ago that management of the Regulatory submission in regards to classification, was a monumental disaster, that reflected very poorly on management.
    So this is now confirmed by the fact that the authorities feel compelled to describe the submission as "poor".
    Now we have a Director undertaking a review of Regulatory Process - probably a Year to late.

    Time for Mercer and the others to be moved on - this is an unmitigated disaster, and reeks of stupendous incompetence.

    I am continually staggered by BIO companies with idiots on the board - no wonder so few make in this country, despite great products.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.